Brunei vs South-Eastern Asia: Proportion of the target population who received the final dose
Brunei
88.0%
in 2024
South-Eastern Asia
51.0%
in 2024
Brunei rank
14th
South-Eastern Asia rank
13th
Proportion of the target population who received the final dose over time
- Brunei
- South-Eastern Asia
How they compare
Brunei currently reports 88.0% against 51.0% in South-Eastern Asia, a difference of 37.0%.
That makes Brunei's figure about 1.7 times South-Eastern Asia's.
Across all 13 years both countries report, Brunei has been ahead every year.
Brunei ranks 14th and South-Eastern Asia ranks 13th of 108 countries.
Brunei has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brunei | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.8% | 6.9% | 77.9% | Brunei |
| 2020s | 88.2% | 19.2% | 69.0% | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Brunei or South-Eastern Asia?
- Brunei, at 88.0% against 51.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Brunei and South-Eastern Asia?
- 37.0%, with Brunei ahead.
- How many years of comparable data are there for Brunei and South-Eastern Asia?
- 13 years are reported by both, from 2012 to 2024.
- How do Brunei and South-Eastern Asia rank globally for proportion of the target population who received the final dose of?
- Brunei ranks 14th and South-Eastern Asia ranks 13th of 108 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.